Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis

被引:16
作者
Vandorpe, DH
Wilhelm, S
Jiang, LW
Ibraghimov-Beskrovnaya, O
Chernova, MN
Sturt-Tilley, AK
Alper, SL
机构
[1] Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA
[5] Genzyme Corp, Framingham, MA 01701 USA
关键词
Xenopus oocyte; EcR-293; cells; polycystin-2; 2-aminophenylborate; intracellular calcium; autosomal dominant polycystic kidney disease;
D O I
10.1152/physiolgenomics.00092.2001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Polycystin-1 (PKD1) mutations account for similar to85% of autosomal dominant polycystic kidney disease (ADPKD). We have shown previously that oocyte surface expression of a transmembrane fusion protein encoding part of the cytoplasmic COOH terminus of PKD1 increases activity of a Ca2+-permeable cation channel. We show here that human ADPKD mutations incorporated into this fusion protein attenuated or abolished encoded cation currents. Point mutations and truncations showed that cation current expression requires integrity of a region encompassing the putative coiled coil domain of the PKD1 cytoplasmic tail. Whereas these loss-of-function mutants did not exhibit dominant negative phenotypes, coexpression of a fusion protein expressing the interacting COOH-terminal cytoplasmic tail of PKD2 did suppress cation current. Liganding of the ectodomain of the PKD1 fusion protein moderately activated cation current. The divalent cation permeability and pharmacological profile of the current has been extended. Inducible expression of the PKD1 fusion in EcR-293 cells was also associated with activation of cation channels and increased Ca2+ entry.
引用
收藏
页码:87 / 98
页数:12
相关论文
共 48 条
[1]   Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease [J].
Arnaout, MA .
ANNUAL REVIEW OF MEDICINE, 2001, 52 :93-123
[2]  
Arnould T, 1999, MOL CELL BIOL, V19, P3423
[3]   The polycystic kidney disease 1 gene product mediates protein kinase C α-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1 [J].
Arnould, T ;
Kim, E ;
Tsiokas, L ;
Jochimsen, F ;
Grüning, W ;
Chang, JD ;
Walz, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6013-6018
[4]   Mutational analysis within the 3′ region of the PKD1 gene [J].
Badenas, C ;
Torra, R ;
San Millán, JL ;
Lucero, L ;
Milà, M ;
Estivill, X ;
Darnell, A .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1225-1233
[5]  
Benzing T, 2000, J BIOL CHEM, V275, P28167
[6]   PREDICTING COILED COILS BY USE SF PAIRWISE RESIDUE CORRELATIONS [J].
BERGER, B ;
WILSON, DB ;
WOLF, E ;
TONCHEV, T ;
MILLA, M ;
KIM, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8259-8263
[7]   The structure of a PKD domain from polycystin-1: Implications for polycystic kidney disease [J].
Bycroft, M ;
Bateman, A ;
Clarke, J ;
Hamill, SJ ;
Sandford, R ;
Thomas, RL ;
Chothia, C .
EMBO JOURNAL, 1999, 18 (02) :297-305
[8]   Polycystin-L is a calcium-regulated cation channel permeable to calcium ions [J].
Chen, XZ ;
Vassilev, PM ;
Basora, N ;
Peng, JB ;
Nomura, H ;
Segal, Y ;
Brown, EM ;
Reeders, ST ;
Hediger, MA ;
Zhou, J .
NATURE, 1999, 401 (6751) :383-386
[9]   Transport function of the naturally occurring pathogenic polycystin-2 mutant, R742X [J].
Chen, XZ ;
Segal, Y ;
Basora, N ;
Guo, L ;
Peng, JB ;
Babakhanlou, H ;
Vassilev, PM ;
Brown, EM ;
Hediger, MA ;
Zhou, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (05) :1251-1256
[10]   The membrane anchor influences ligand binding two-dimensional kinetic rates and three-dimensional affinity of FcγRIII (CD16) [J].
Chesla, SE ;
Li, P ;
Nagarajan, S ;
Selvaraj, P ;
Zhu, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10235-10246